Potential Role of SWI/SNF Complex Subunit Actin-Like Protein 6A in Cervical Cancer

Overview

Journal Front Oncol

Specialty Oncology

Date 2021 Aug 16

PMID 34395295

Authors

Qingying Wang

Zuozeng Cao

Yingze Wei

Jiawen Zhang

Zhongping Cheng

Affiliations

Soon will be listed here.

Abstract

SWI/SNF complex subunit Actin-like protein 6A (ACTL6A) has been regarded as an oncogene, regulating the proliferation, migration and invasion of cancer cells. However, the expression pattern and biological role of ACTL6A in cervical cancer have not been reported. In this study, the mRNA expression and protein level of ACTL6A in cervical cancer samples were determined by public database and immunohistochemical (IHC) analysis. The effects of ACTL6A on cervical cancer cells were investigated MTT, colony-formation assay, tumor xenografts and flow cytometry. Gene set enrichment analysis (GSEA) was used to explore the potential mechanism of ACTL6A in regulating tumorigenesis of cervical cancer. The results revealed that ACTL6A was markedly upregulated in cervical cancer tissues. Silencing ACTL6A expression resulted in decreased cervical cancer cell proliferation, colony formation and tumorigenesis and . Furthermore, we demonstrated that knockdown of ACTL6A induced cell cycle arrest at G1 phase, ACTL6A-mediated proliferation and cell cycle progression were c-Myc dependent. Our study provides the role of ACTL6A in cervical oncogenesis and reveals a potential target for therapeutic intervention in this cancer type.

References

Baluapuri A, Wolf E, Eilers M . Target gene-independent functions of MYC oncoproteins. Nat Rev Mol Cell Biol. 2020; 21(5):255-267. PMC: 7611238. DOI: 10.1038/s41580-020-0215-2. View

Zhong P, Zhong L, Yao J, Liu D, Yuan Z, Liu J . ACTL6A interacts with p53 in acute promyelocytic leukemia cell lines to affect differentiation via the Sox2/Notch1 signaling pathway. Cell Signal. 2018; 53:390-399. DOI: 10.1016/j.cellsig.2018.11.009. View

Bao X, Tang J, Lopez-Pajares V, Tao S, Qu K, Crabtree G . ACTL6a enforces the epidermal progenitor state by suppressing SWI/SNF-dependent induction of KLF4. Cell Stem Cell. 2013; 12(2):193-203. PMC: 3661004. DOI: 10.1016/j.stem.2012.12.014. View

Wang Y, Hoang L, Ji J, Huntsman D . SWI/SNF Complex Mutations in Gynecologic Cancers: Molecular Mechanisms and Models. Annu Rev Pathol. 2020; 15:467-492. PMC: 6986318. DOI: 10.1146/annurev-pathmechdis-012418-012917. View

Zhang J, Zhang J, Wei Y, Li Q, Wang Q . ACTL6A regulates follicle-stimulating hormone-driven glycolysis in ovarian cancer cells via PGK1. Cell Death Dis. 2019; 10(11):811. PMC: 6813335. DOI: 10.1038/s41419-019-2050-y. View

Xiao S, Chang R, Yang M, Lei X, Liu X, Gao W . Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition. Hepatology. 2015; 63(4):1256-71. PMC: 4834727. DOI: 10.1002/hep.28417. View

Gao J, Aksoy B, Dogrusoz U, Dresdner G, Gross B, Sumer S . Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013; 6(269):pl1. PMC: 4160307. DOI: 10.1126/scisignal.2004088. View

Lee K, Lee A, Kwon Y, Kwon H . Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells. Biochem Biophys Res Commun. 2011; 412(2):328-33. DOI: 10.1016/j.bbrc.2011.07.098. View

He L, Liu H, Tang L . SWI/SNF chromatin remodeling complex: a new cofactor in reprogramming. Stem Cell Rev Rep. 2011; 8(1):128-36. DOI: 10.1007/s12015-011-9285-z. View

10.

Zhang J, Wang L, Qiu M, Liu Z, Qian W, Yang Y . The protein levels of MCM7 and p63 in evaluating lesion severity of cervical disease. Int J Gynecol Cancer. 2013; 23(2):318-24. DOI: 10.1097/IGC.0b013e31827f6f06. View

11.

Li R, Li Y, Qin H, Li S . ACTL6A Promotes the Proliferation of Esophageal Squamous Cell Carcinoma Cells and Correlates with Poor Clinical Outcomes. Onco Targets Ther. 2021; 14:199-211. PMC: 7812043. DOI: 10.2147/OTT.S288807. View

12.

Saladi S, Ross K, Karaayvaz M, Tata P, Mou H, Rajagopal J . ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis. Cancer Cell. 2017; 31(1):35-49. PMC: 5225026. DOI: 10.1016/j.ccell.2016.12.001. View

13.

Zeng Z, Yang H, Xiao S . ACTL6A expression promotes invasion, metastasis and epithelial mesenchymal transition of colon cancer. BMC Cancer. 2018; 18(1):1020. PMC: 6198485. DOI: 10.1186/s12885-018-4931-3. View

14.

Jian Y, Huang X, Fang L, Wang M, Liu Q, Xu H . Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer. J Exp Clin Cancer Res. 2021; 40(1):56. PMC: 7863242. DOI: 10.1186/s13046-021-01856-3. View

15.

Mittal P, Roberts C . The SWI/SNF complex in cancer - biology, biomarkers and therapy. Nat Rev Clin Oncol. 2020; 17(7):435-448. PMC: 8723792. DOI: 10.1038/s41571-020-0357-3. View

16.

Ji J, Xu R, Zhang X, Han M, Xu Y, Wei Y . Actin like-6A promotes glioma progression through stabilization of transcriptional regulators YAP/TAZ. Cell Death Dis. 2018; 9(5):517. PMC: 5938705. DOI: 10.1038/s41419-018-0548-3. View

17.

Son E, Crabtree G . The role of BAF (mSWI/SNF) complexes in mammalian neural development. Am J Med Genet C Semin Med Genet. 2014; 166C(3):333-49. PMC: 4405377. DOI: 10.1002/ajmg.c.31416. View

18.

Ribeiro-Silva C, Vermeulen W, Lans H . SWI/SNF: Complex complexes in genome stability and cancer. DNA Repair (Amst). 2019; 77:87-95. DOI: 10.1016/j.dnarep.2019.03.007. View

19.

Park J, Wood M, Cole M . BAF53 forms distinct nuclear complexes and functions as a critical c-Myc-interacting nuclear cofactor for oncogenic transformation. Mol Cell Biol. 2002; 22(5):1307-16. PMC: 134713. DOI: 10.1128/MCB.22.5.1307-1316.2002. View

20.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View